Prevention of Bacterial Endocarditis
Adnan S. Dajani(Unknown), Gregory Zuccaro(Unknown), Matthew E. Levison, Patricia Ferrieri, CECILIA HUTTO(American Heart Association), Jane W. Newburger(Oregon Health & Science University), Ann F. Bolger, Thomas J. Pallasch(Pallas (Germany)), Michael H. Gewitz(New York Medical College), Walter R. Wilson(Mayo Clinic in Arizona), Soraya Nouri, Stanford T. Shulman(Lurie Children's Hospital), Tommy W. Gage, Kathryn A. Taubert(Southwestern Medical Center), Georges Peter(American Heart Association), Arnold S. Bayer(University of California, Los Angeles)
Cited by 388
Related Papers
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
|Clinical Infectious Diseases|2011|4.2k
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa
|Clinical Infectious Diseases|2012|2.2k